|Shawn H. Eung, B.S., M.B.A.
Grant Manager, Department of Medicine | Section of Hematology and Medical Oncology Boston Medical CenterEmail email@example.com Phone 617 414-5774 Fax 617 638-7530 Office Location 650 Albany Street, EBRC 407, Boston, MA 02118
|Lillian C. McMahon, M.D.
Associate Professor of Medicine and Pediatrics,
Boston University School of Medicinelillian.firstname.lastname@example.org
|Dr. McMahon is Professor of Pediatrics and Medicine at Boston University School of Medicine. She graduated from Faculdade Federal de Medicina e Cirurgia in Brazil and did her internship and one year of medical residency at Carney Hospital in Dorchester, MA, completing a residency in Pediatrics at Boston City Hospital. Dr. McMahon was a fellow in adult and pediatric hematology in the Tufts University Service at Boston City Hospital, and a fellow in Pediatric Hematology/Oncology at New York Hospital/Cornell Medical Center in New York. Her long time interests are in hemoglobinopathies, in particular sickle cell disease and thalassemia.|
|David H.K. Chui, M.D.
Director, Hemoglobin Diagnostic Reference Laboratory
Professor of Medicine and Pathology, Boston University School of Medicine
|Dr. Chui is Professor of Medicine and Pathology at Boston University School of Medicine. He graduated from University of Maryland and McGill University Faculty of Medicine (1963), received internal medicine postgraduate training in Montreal and Philadelphia, and hematology fellowship at Columbia-Presbyterian Medical Center in New York. He was on the faculty of McMaster University, Hamilton, ON, 1970-2002. He served on the NIH hematology study section, 1987-1991; and was elected to membership of American Society for Clinical Investigation and Association of American Physicians. He has had a long-standing interest in developmental biology of erythropoiesis; hemoglobin ontogeny; and molecular genetics, genotype/phenotype correlation, and population health in hemoglobin disorders.|
|Hong Yuan Luo, M.B., Ph.D.
Assistant Director, Hemoglobin Diagnostic Reference Laboratory
Research Assistant Professor of Medicine, Boston University School of Medicine
|Dr. Luo received her medical education in Guangzhou, China, and her Ph.D. degree in Medical Sciences from the McMaster University, Hamilton, ON, Canada in 1993. Subsequently, she held appointments at the Children’s Hospital in UT Galveston, TX, and also at the University of Pennsylvania in Philadelphia. She joined Boston University in February 2003. Dr. Luo has been interested in hemoglobin ontogeny and regulation, and has published meritorious work on these subject matters. She has generated monoclonal antibodies against human embryonic hemoglobins that can serve as useful reagents in clinical diagnostics.|
|Lance Davis, M.D.
Laboratory Manager, Hemoglobin Diagnostic Reference Laboratory
Boston University School of Medicine
Boston Medical Center
|Martin Steinberg, M.D.
Professor of Medicine, Pediatric, Pathology and Laboratory Medicine, Department of Medicine at Boston University School of Medicine
Section of Hematology and Medical Oncology
Boston Medical Center
Email email@example.com Phone 617 414-1020 Fax 617 414-1021 Office Location 72 East Concord Street, Evans 248, Boston, MA 02118
|Dr. Steinberg is Professor of Medicine, Pediatric, Pathology and Laboratory Medicine, Department of Medicine at Boston University School of Medicine. He graduated from Cornell University and received his medical degree from Tufts University School of Medicine. Dr. Steinberg was an intern in Internal Medicine at Bellevue Hospital Center in New York City and completed his residency training at the Tufts-New England Medical Center in Boston where he also was a fellow in Hematology. He is a Diplomat of the American Board of Internal Medicine and is also a Diplomat of the American Board of Internal Medicine in the subspecialty of Hematology. Dr. Steinberg has had long-term clinical interest in disorders of red blood cell with a special focus on inherited disorders of hemoglobin and sickle cell disease. His research encompasses the structure, function and synthesis of abnormal hemoglobins, how other genes influence the phenotype of sickle cell disease, fetal hemoglobin regulation and clinical trials of innovative treatments for sickle cell disease.|
|Lindsay A. Farrer, Ph.D.
Chief, Genetics Program
Boston University School of Medicine
|Dr. Lindsay Farrer is Chief of the Genetics Program, Director of the Genetic Epidemiology Center, and a Professor of Medicine at Boston University Schools of Medicine. He is a graduate of the University of North Carolina in Chapel Hill, received his Ph.D. from the Indiana University School of Medicine and gained additional training in genetic epidemiology at Yale University. Dr. Farrer’s research has lead to more than 150 publications on genetic risk factors for several familial neurodegenerative and other chronic diseases. In collaboration with other laboratories worldwide, his group has localized genes causing a variety of rare and common disorders including Alzheimer disease (AD), Wilson disease, Machado-Joseph disease, Waardenburg syndrome, hypertension, sensorineural deafness, and osteoarthritis. Dr. Farrer’s team is developing genetic mapping methods for locating genetic modifiers for disorders whose primary defects are already known, but account for only a small portion of the phenotypic variation.|
|Elizabeth Klings, M.D.
Associate Professor of Medicine, Department of Medicine Boston | University School of Medicine
Program Director | Center of Excellence in Sickle Cell Disease Director | Pulmonary Hypertension Inpatient and Education Program Medical Director | Pulmonary Rehabilitation Program Boston Medical CenterEmail Klingon@bu.edu Phone 617 638-8679 Fax 617 638-5227 Office Location 72 East Concord Street, R-304, Boston, MA 02118
|Dr. Klings is Assistant Professor of Medicine in the Pulmonary Center at Boston University School of Medicine. After graduating from New York University’s College of Arts and Sciences and School of Medicine, Dr. Klings completed residency training in Internal Medicine at Boston City Hospital and fellowship training in Pulmonary and Critical Care at Boston University School of Medicine. Her clinical and research interests encompass the pathophysiology and treatment of pulmonary vascular disease. Currently, she is evaluating the role of altered oxidative stress in the endothelial dysfunction observed in the acute chest syndrome of sickle cell disease.|
Graduate Student, Biostatistics
|Duyen Ngo, M.D.
Assistant Professor, Boston University School of Medicine
Clinic Director, Boston Medical Center
|Dr. Ngo graduated from Harvard University and received her medical degree from the University of Minnesota Medical School. She completed her internal medicine residency at Massachusetts General Hospital and fellowship in hematology and oncology at Boston Medical Center. Her research as a Sickle Cell Scholar will focus on understanding genetic determinants of hemoglobin F levels and other modifiers of clinical phenotype in patients with sickle cell disease.|
|Susan Perrine, M.D.
Cancer Center, Boston University Medical Center
Associate Professor of Pediatrics and Medicine, Boston Univ. School of Medicine
|Dr. Perrine is Associate Professor of Pediatrics, Medicine, Pharmacology and Experimental Therapeutics, and Director of the Hemoglobinopathy-Thalassemia Research Unit at Boston University School of Medicine. She received a BA from Mills College, Masters degrees from Harvard School of Public Health and Robert Wood Johnson School of Medicine, and her M.D. from Tufts University School of Medicine. She completed her Pediatric Residency training at Tufts-New England Medical Center and a Hematology-Oncology fellowship at The Children’s Hospital, Boston, Dana Farber Cancer Institute, and Harvard Medical School. She is Board Certified in Pediatrics and Pediatric Hematology-Oncology. Dr. Perrine’s research has focused on investigation of methods to reactivate the fetal hemoglobin gene, using agents that are safe for life-long use beginning in childhood, for the amelioration of sickle cell anemia and beta thalassemia. She directs a basic science laboratory and clinical trials in these disorders and viral-associated malignancies.|
|Paola Sebastiani, Ph.D.
Professor of Biostatistics
Boston University School of Public Health
|Dr. Sebastiani joined the Department of Biostatistics in 2003 as an Associate Professor, after holding faculty positions in Italy, England and United States. She is the author of over 70 peer-reviewed publications in theoretical and methodological statistics, artificial intelligence and computational biology. She is a member of the editorial board of the Machine Learning journal and Evaluation of Intelligent Systems. She is also a regular reviewer for major journals in statistics and computer science, and serves on the program committee of several international conferences at the interface between statistics and artificial intelligence. Paola’s research interests focus primarily on the development of Bayesian methods and their application to a wide spectrum of problems, ranging from cognitive robotics to bioinformatics, from biosurveillance to knowledge discovery. She is particularly interested in the development of automated analytical methods and many of her methodological contributions have been implemented in computer programs, such as Bayesware Discoverer: the first publicly available program for the automated discovery of Bayesian networks from incomplete databases, and Caged, a program for Bayesian model-based clustering of gene expression profiles measured in temporal experiments. Paola is founder of Bayesware LLC, a software company developing and commercializing knowledge discovery programs based Bayesian methods.|
|Philippa G. Sprinz, M.D.
Chief, Pediatric Hematology
Boston Medical Center
|Philippa G. Sprinz, M.D, attended Aberdeen University Medical School, Scotland and following 2 years of medical training in Great Britain, completed a residency in Pediatrics at University of Miami School of Medicine/Jackson Memorial Hospital, Miami. Following her fellowship in Pediatric Hematology/Oncology at Jackson Memorial Hospital, she was Medical Director, Division of Pediatric Hematology/Oncology, Joe DiMaggio Children’s Hospital at Memorial, Hollywood, Florida and most recently, Director, Division of Pediatric Hematology/Oncology, Baystate Medical Center. She has recently joined the staff at Boston Medical Center as the Chief of Pediatric Hematology.|
|In the process of updating the website 04/02/15|